Tourmaline Financial Statements From 2010 to 2026
| TRMLDelisted Stock | 47.98 0.00 0.00% |
Check Tourmaline Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tourmaline Bio's main balance sheet or income statement drivers, such as , as well as many indicators such as . Tourmaline financial statements analysis is a perfect complement when working with Tourmaline Bio Valuation or Volatility modules.
Tourmaline |
Tourmaline Bio Company Return On Equity Analysis
Tourmaline Bio's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Tourmaline Bio Return On Equity | -0.3 |
Most of Tourmaline Bio's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tourmaline Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Tourmaline Bio has a Return On Equity of -0.2962. This is 98.76% lower than that of the Biotechnology sector and 99.19% lower than that of the Health Care industry. The return on equity for all United States stocks is 4.45% lower than that of the firm.
Tourmaline Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tourmaline Bio's current stock value. Our valuation model uses many indicators to compare Tourmaline Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tourmaline Bio competition to find correlations between indicators driving Tourmaline Bio's intrinsic value. More Info.Tourmaline Bio is rated fourth in return on equity category among its peers. It is rated fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Tourmaline Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Tourmaline Bio Financial Statements
Tourmaline Bio investors utilize fundamental indicators, such as revenue or net income, to predict how Tourmaline Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Tourmaline Stock
If you are still planning to invest in Tourmaline Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tourmaline Bio's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |